Immunogen Inc. (IMGN) Posts Q1 Loss of $0.22; Reaffirms Guidance
IMGN Hot Sheet
Revenue Growth %: -37.5%Financial Fact:
Total operating expenses: 21.95M
Today's EPS Names:
TARO, BRLI, TLB, More
Immunogen Inc. (NASDAQ: IMGN) reports Q1 loss of $0.22, cents better than the analyst estimate of ($0.20). Revenue for the quarter was $3.10 million, which compares to the estimate of $4.54 million.
Reaffirms guidance.
Reaffirms guidance.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Toro Co. (TTC) Tops Q1 EPS by 13c; Guides FY12 EPS Above Views; to Split Stock
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
